Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Reaffirmed by Truist Financial tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, May 3rd. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Amneal Pharmaceuticals has set its FY 2024 guidance at 0.530-0.630 EPS.Parties that are interested in participating in […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares traded. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth Several equities research analysts […]
Truist Financial restated their buy rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the stock. Several other research firms also recently commented on AMRX. StockNews.com started coverage on Amneal Pharmaceuticals in a report on […]